Prevalence of methylenetetrahydrofolate reductase mutations in patients with venous thrombosis.
- 1 March 2000
- journal article
- Vol. 5 (1)
- https://doi.org/10.1054/MODI00500059
Abstract
The objectives of this study are to examine the prevalence of combined methylenetetrahydrofolate reductase (MTHFR) 677C-->T and 1298A-->C mutations in patients with venous thrombosis (VT) and healthy volunteers and to determine if these mutations are in Hardy-Weinberg equilibrium.Keywords
This publication has 30 references indexed in Scilit:
- Thermolabile Methylenetetrahydrofolate Reductase and Factor V Leiden in the Risk of Deep-Vein ThrombosisThrombosis and Haemostasis, 1998
- Oral Contraceptives and Thrombotic Disease: Risk of Venous ThromboembolismThrombosis and Haemostasis, 1997
- Clinical chemistry and molecular biology of homocysteine metabolism: An updateClinical Biochemistry, 1997
- Hyperhomocyst(e)inemia and AtherothrombosisaAnnals of the New York Academy of Sciences, 1997
- Risk of Venous Thrombosis in Carriers of a Common Mutation in the Homocysteine Regulatory Enzyme Methylenetetrahydrofolate Reductase.Published by Georg Thieme Verlag KG ,1997
- Relation Between Folate Status, a Common Mutation in Methylenetetrahydrofolate Reductase, and Plasma Homocysteine ConcentrationsCirculation, 1996
- A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular DiseaseJAMA, 1995
- Homocysteine metabolism in pregnancies complicated by neural-tube defectsThe Lancet, 1995
- High frequency (71%) of cystathionine β-synthase mutation G307S in Irish homocystinuria patientsHuman Mutation, 1995
- Hyperhomocysteinemia: a risk factor in women with unexplained recurrent early pregnancy lossFertility and Sterility, 1993